SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2017 San Francisco, CA
Activity/Course #:
: 08.19.17PC
Cost:
: Free
Release/Start Date:
: Aug 19 2017
Expiration Date:
: Aug 19 2017
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 6.0 hours
Credit(s):
: 6.0 AMA PRA Category I Credit(s)
6.0 AANP Contact hour(s)
Hardware/Software Requirements:
(Chrome not supported at this time)

Saturday, August 19, 2017

San Mateo Marriott San Francisco Airport
1770 S. Amphlett Blvd
San Mateo, CA 94402
(650) 653-6000

Registration Fee

There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking

Complimentary self-parking is available at the hotel.

Hotel Guest Rooms

NACE has reserved a sleeping room rate of $139 per night at the San Mateo Marriott San Francisco Airport Hotel. To reserve your room at this rate, call reservations at (866) 263-1461 and ask for the NACE room block by July 28, 2017.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:

  1. Describe the role of the kidney in glucose metabolism in health and disease; Review the physiologic effects and clinical efficacy of SGLT-2 therapy in various patient populations; Review emerging data on possible renal and macrovascular effects of evidence-based diabetes treatment options; Integrate the impact of treatment decisions on postprandial hyperglycemia and risk of hypoglycemia.

  2. Differentiate adrenal gland disorders and classify them as either hyperfunctioning or hypofunctioning based on the provided clinical and laboratory information; Recognize the preferred treatment option(s) for specific adrenal gland disorders; Prepare a patient-specific monitoring plan for medications used in the management of adrenal gland disorders and anticipate new medication-related problems.

  3. Describe the typical clinical presentation of a patient with possible idiopathic pulmonary fibrosis (IPF); Discuss the diagnostic approach to a patient with suspected IPF; Discuss and contrast the available pharmacotherapeutic options for patients with IPF; Discuss and contrast the available nonpharmacotherapeutic options for patients with IPF.

  4. To be determined.

  5. List 2017 Quality Measures for the use of statin therapy for the prevention and treatment of cardiovascular disease; Explain the role of anti-PCSK9 monoclonal antibody therapy in LDL-C reduction to achieve cardiovascular risk reduction; Discuss ACC guidelines on the role of non-statin therapies in the management of atherosclerotic cardiovascular disease; Employ guideline-directed treatment strategies for primary and secondary prevention of cardiovascular disease in high-risk patient populations.


Agenda*

7:15-7:50   Continental Breakfast and Registration
7:50-8:00   Welcome Remarks
Deborah Paschal, CRNP
8:00-9:10  

Integrating Data on Macrovascular and Microvascular Outcomes into Diabetes Management: Evolving Treatment Strategies
Robert Busch, MD, FACE

9:10-10:20   Presentation Theatre: Therapeutic Options for Hypertension Management
(CME not offered)
10:20-11:30   Wax Museum Endocrinology: The Adrenal and Pituitary
Robert Busch, MD, FACE
11:30-12:40   Idiopathic Pulmonary Fibrosis: Defining the Role of the Primary Care Clinician in Diagnosis and Therapy
Fernando J. Martinez, MD, MS
12:40-1:50  

Lunch

Presentation Theater: Awaken a Transformation in Type 2 Diabetes Management
(CME not offered)

1:50-3:00  
To be determined
3:00-3:10  

Break

 3:10-4:00 

Presentation Theater: Setting Families up for Nutrition Success
(CME not offered)

   4:00-5:10 

New Agents, New Options, and Expanded Potential In Lipid Management: Integrating The Data Into Practice
Karol E. Watson, MD, PhD

 5:10-5:15 

Program Summary and Closing Remarks
Deborah Paschal, CRNP

 *Agenda subject to change.

Faculty

Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA

Robert S. Busch, MD, FACE
Director of Clinical Research
Albany Medical Faculty: Community Endocrine Group
Albany, NY

Fernando J. Martinez, MD, MS
Chief, Division of Pulmonary and Critical Care Medicine
Bruce Webster Professor of Medicine

Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, NY

Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program
Los Angeles, CA

Planning Committee

Gregg Sherman, MD
Course Director
National Association for Continuing Education

Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer

Association of Black Cardiologists

New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL


Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 6 contact hours of continuing education (which includes pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
Emerging Challenges in Primary Care: 2017 is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.; an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.; and an educational grant from Sanofi US and Regeneron Pharmaceuticals.